Jeffery Holford

Jefferies on Monday issued a report on Pfizer Inc. (NYSE: PFE), raising its price target from $42 to $45. Jefferies rates Pfizer as a Buy. Analysts Jeffrey Holland, David Gu, Ian Hilliker and Sissi Qiong Hai wrote, "We expect Pfizer shares to significantly appreciate over the next 1-2 years based...